TuHURA Biosciences, Inc.
HURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498382
No open-market purchases or sales by TuHURA Biosciences, Inc. insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding TuHURA Biosciences, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 26 | 25 | −1 |
| Shares | 3.91M | 3.47M | −441.5K (−11.3%) |
| Value | $1.99M | $1.35M | −$644.7K (−32.3%) |
New holders (5)
Institutions that held TuHURA Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 13,898 | $6.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 14,677 | $6.00K | 0.00% |
| Prospera Financial Services Inc | 3,078 | $1.00K | 0.00% |
| FMR LLC | 140 | $0 | 0.00% |
| Citigroup Inc | 500 | $0 | 0.00% |
Sold out (6)
Institutions that held TuHURA Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Citadel Advisors LLC | 248,329 | $127.0K |
| Two Sigma Securities, LLC | 46,661 | $24.0K |
| Two Sigma Investments, LP | 34,624 | $18.0K |
| Susquehanna International Group, LLP | 32,257 | $16.0K |
| Two Sigma Advisers, LP | 30,100 | $15.0K |
| St. Johns Investment Management Company, LLC | 125 | $0 |